Postdoctoral Training Fellow - Pre-Clinical MRI for Adaptive Radiotherapy

18/10/2019, 23:55

Sutton
Radiotherapy and Imaging
Magnetic Resonance
Full time
Fixed Term
3 years
35
£32,200 - £37,850
The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment.

Under the leadership of our Chief Executive, Professor Paul Workman FRS, the ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top four cancer centres globally.

The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer.

The pre-clinical magnetic resonance team, led by Dr. Simon Robinson, is focused on the application of both established and innovative, quantitative functional MRI techniques to identify case-specific imaging biomarkers in models of cancer in vivo, thereby establishing their utility to correctly inform on i) the pathology and processes relevant to a particular cancer type, and ii) response/resistance to treatment against these processes.  There is a strong emphasis on the development of quantitative MRI biomarkers that can be realistically translated and prove informative in aligned imaging investigations of cancer patients.

Through programme grant funding from Cancer Research UK, an early-stage post-doctoral training fellow position is available to exploit MRI for adaptive radiotherapy in pre-clinical models of cancer.  We are looking for a highly motivated and creative individual to evaluate the utility of MRI-derived biomarkers of tumour hypoxia to predict radiation response, and their potential use in enhancing radiotherapy efficacy, using a small animal radiation research platform (SARRP).

The position will be based within the Centre for Cancer Imaging, which provides an integrated environment for multi-modality pre-clinical imaging, co-locating a pre-clinical 7T MRI system with the SARRP.  The position will provide excellent opportunities to interact within a multidisciplinary environment of staff within imaging, radiotherapy, drug development and molecular pathology teams, and explore new avenues of research.

Applicants should possess a PhD in physical or biomedical science, and ideally have demonstrated excellence in the field of pre-clinical MRI and/or radiotherapy, as evidenced by peer-reviewed publications and productivity during their PhD studies.

Appointment will be on a Fixed Term Contract for 3 years in the first instance. The starting salary is £37,850 per annum  (£32,200 for pre-viva post-holders)

We consider all applications on merit and have a strong commitment to enhancing the diversity of our staff.
Additional Documentation for Candidates